AACC uses cookies to ensure the best website experience. Continuing without changing cookie settings assumes you consent to our use of cookies on this device. You can change these settings at any time, but that may impair functionality on our websites. Review our cookie and privacy policy

Exploring MolDX and Payer Guidelines for Molecular Testing

  • Credit:1.0 ACCENT
  • Duration: 1 hour
  • Date:JAN.25.2023 12:00 p.m. - 01:00 p.m.
  • Level: Intermediate

Price: $0.00

Member Price: $0.00

Your registration includes access to the recording on demand through January 31, 2024.

DESCRIPTION

Labs performing molecular infectious disease testing within a MolDX jurisdiction must now register for a unique DEX code z-identifier to receive a fixed reimbursement for laboratory developed tests or “expanded” panels that test for more than five targets. During this webinar we will review the MolDX program, and under which conditions the labs need to apply for a new Z-code.

At the end of the webinar the attendees will have an understanding of the reimbursement landscape for molecular testing and how the new MolDX requirements should be applied in daily routine.

TARGET AUDIENCE

This activity is designed for physicians, lab supervisors, lab directors (and/or assistant directors), lab managers (supervisory and/or non-supervisory), medical technologists, point-of-care coordinators, pathologists, in-training individuals, and other laboratory professionals overseeing/conducting within this topic.

LEARNING OBJECTIVES

At the end of this activity, participants will be able to:

  • Define what MolDX and Z-codes are.
  • Identify the rules for payment in Local Coverage Determinations (LCDs)/Payer Policy.
  • Explain Laboratory Benefit Management (LBM) and its role in payer policy and reimbursement for laboratory testing
  • Define the role of Medical Necessity in the reimbursement landscape.

FACULTY

Jon HarolJon Harol
Founder/President
Lighthouse Lab Services
Charlotte, NC, USA

Ann LambrixAnn Lambrix
Vice President, RCM Solutions
Lighthouse Lab Services
Charlotte, NC, USA

DISCLOSURES AND STATEMENT OF INDEPENDENCE

AACC is dedicated to ensuring balance, independence, objectivity, and scientific rigor in all educational activities. All participating planning committee members and faculty are required to disclose to the program audience any financial relationships related to the subject matter of this program. Disclosure information is reviewed in advance in order to manage and resolve any possible conflicts of interest. The intent of this disclosure is to provide participants with information on which they can make their own judgments.

The following faculty reported no relevant financial relationship:

  • Jon Harol
  • Ann Lambrix

CONTENT VALIDITY

All recommendations involving clinical medicine are based on evidence accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients; AND/OR all scientific research referred to or reported in support or justification of a patient care recommendation conforms to generally accepted standards of experimental design, data collection, and analysis.

ACCREDITATION STATEMENT

This activity is approved for 1.0 ACCENT® continuing education credits. Activity ID# 4165. This activity was planned in accordance with ACCENT® Standards and Policies.

SUCCESSFUL COMPLETION STATEMENT

Verification of Participation certificates are provided to registered participants based on completion of the activity, in its entirety, and the activity evaluation. For questions regarding continuing education, please email [email protected].

Sponsored By

Thermo Fisher Logo